Panelists discuss how early identification of Type 1 diabetes through screening programs, combined with emerging therapies like teplizumab, offers new opportunities for intervention and improved patient outcomes in at-risk populations.
The FDA, women's health groups and professional societies, and state governors are all pushing back against the April 7 ruling by Texas District Judge Matthew Kacsmaryk.
Based on its acceptance of the resubmission, FDA has assigned a PDUFA action goal date of January 31, 2025 for AXS-07.
Obesity Medicine Association President Craig Primack, MD, reminds PCPs that stress management is a key to good self care for everyone and offers tips to share with patients.
Findings of the BOREAS trial of patients with COPD and type 2 inflammation make dupilumab the first biologic to significantly reduce exacerbations by 30% vs placebo.
The new e-commerce partnership expands access to Opill by allowing direct delivery of the contraceptive to consumers' homes without a prescription.
Two official US vaccine planning meetings cancelled in February is an "unprecedented situation," said NFID medical director Robert Hopkins, Jr, MD.
Panelists discuss key insights on the importance of early screening for T1D, the role of antibody testing in identifying at-risk individuals, and the need for timely intervention to preserve ß-cell function and optimize long-term management strategies for better patient outcomes.
Raj Chovatiya, MD, PhD, MSCI, actually said symptoms "never" lie so, particularly in patients with skin of color, if skin signs aren't clear, ask about the patient's experience.
To close this series, experts explore the challenges and guideline gaps in multi-cancer early detection while considering its potential impact on patient care, accessibility, and improved outcomes.
Benjamin W. Friedman, MD, MS; Francesca Beaudoin, MD, MS, PhD; Paul Arnstein, RN, PhD, FAAN; and Jeff Gudin, MD, provide take-home messages to providers treating patients with acute pain.
Dr Turner reviews the profile of the individual who is most likely to benefit from lecanemab therapy.
Pharmacologic treatment to prevent episodic migraine should follow a sequential trial approach that considers medication cost, headache triggers, adherence, and lifestyle interventions.
New research offers insight into how women who use cannabis during pregnancy perceive the impacts of cannabis legalization.
A recent survey reveals some surprising facts about who handles illness better - men or women.
Breast cancer survivors rely on their primary care clinicians as resources integral to their recovery and return to optimal function. Physiatrist Sean Smith, MD, offers details.
After 60 months of treatment, 38% of study participants with severe AD achieved complete remission.
Drs John Russell, Jacinda Abdul-Mutakabbir, Charles Vega, Wendy Wright, And Neil Skolnik provide their practice pearls and key thoughts on how to vaccinate their patient populations in the upcoming influenza season.
A medical director of antimicrobial stewardship at a large metropolitan health system highlights the dangers of AMR and how she believes the pharmaceutical industry could help.
As flu season approaches this year, experts stress that it's not just about influenza anymore; they discuss testing, antiviral treatment, and management of coinfection.
Endocrinology experts discuss the clinical implications of off-target TSH levels and stress the importance of stabilizing these levels for hypothyroidism management.
Benjamin W. Friedman, MD, MS; Francesca Beaudoin, MD, MS, PhD; Paul Arnstein, RN, PhD, FAAN; and Jeff Gudin, MD, provide take-home messages to providers treating patients with acute pain.
Research demonstrates that discussing test results face-to-face with patients during office visits is beneficial for patient and clinician, according to family physician Andrew Carroll, MD.
Geriatric psychiatrist and neurocognitive researcher George Grossberg, MD, highlights the mechanism of action for the new dextromethorphan/bupropion combination.
Pulmonology experts agreed that adopting race-neutral diagnostic and research practices could help mitigate a range of inequities faced by minority populations.
Overscheduled and undertrained, primary care clinicians shoulder a significant portion of the US wound care burden. Author Nima Ahmadi offers a technology-based solution.
Excess weight diminishes the development and function of the musculoskeletal system at any point in the lifespan. An obesity specialist highlights the dangers.
The expert panel concludes by examining strategies for managing hypoglycemia challenges related to dumping syndrome, particularly in the context of continuous glucose monitoring use.
Panelists discuss how early identification of Type 1 diabetes through screening programs, combined with emerging therapies like teplizumab, offers new opportunities for intervention and improved patient outcomes in at-risk populations.